XtalPi Holdings Limited (HKG:2228)

Market Cap	34.64B +68.6%
Revenue (ttm)	893.17M +201.2%
Net Income	137.71M
EPS	0.03
Shares Out	4.30B
PE Ratio	241.13
Forward PE	400.06
Dividend	n/a
Ex-Dividend Date	n/a

Volume	45,094,634
Open	8.40
Previous Close	8.37
Day's Range	7.98 - 8.41
52-Week Range	4.34 - 15.12
Beta	n/a
Analysts	Strong Buy
Price Target	11.60 (+44.1%)
Earnings Date	May 27, 2026

About XtalPi Holdings

XtalPi Holdings Limited operates as a research platform company in Mainland China, the United States, and internationally. The company offers XmartChem, an intelligent synthesis workstation which automates the chemical synthesis process; ChemPlus, desktop solid dispensing device; PatSight, an optical chemical structure extraction tool for patents; and XFEP, a software for rapid FEP calculations using cloud computing. It also provides XMolGen, a generative chemistry tool; and drug discovery solutions, such as hit discovery, hit or lead optimizat...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2015
• Employees: 1,254
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2228

Financial Performance

Financial numbers in CNY